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Parasitic helminth worms, such as Schistosoma mansoni, are endemic in regions with a
high prevalence of tuberculosis (TB) among the population. Human studies suggest that
helminth coinfections contribute to increased TB susceptibility and increased rates of TB
reactivation. Prevailing models suggest that T helper type 2 (Th2) responses induced by
helminth infection impair Th1 immune responses and thereby limit Mycobacterium
tuberculosis (Mtb) control. Using a pulmonary mouse model of Mtb infection, we
demonstrated that S. mansoni coinfection or immunization with S. mansoni egg antigens
can reversibly impair Mtb-specific T cell responses without affecting macrophage-mediated
Mtb control. Instead, S. mansoni infection resulted in accumulation of high arginase-1–
expressing macrophages in the lung, which formed type 2 granulomas and exacerbated
inflammation in Mtb-infected mice. Treatment of coinfected animals with an antihelminthic
improved Mtb-specific Th1 responses and reduced disease severity. In a genetically diverse
mouse population infected with Mtb, enhanced arginase-1 activity was associated with
increased lung inflammation. Moreover, in patients with pulmonary TB, lung damage
correlated with increased serum activity of arginase-1, which was elevated in TB patients
coinfected with helminths. Together, our data indicate that helminth coinfection induces
arginase-1–expressing type 2 granulomas, thereby increasing inflammation and TB disease
severity. These results also provide insight into the mechanisms by which helminth
coinfections drive increased susceptibility, disease progression, and severity in TB.
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Introduction
About one-third of the world’s population is infected with Myco-
bacterium tuberculosis (Mtb), leading to 1.4 million deaths and 8.8 
million new reported cases of pulmonary tuberculosis (TB) every 
year (1). Although most Mtb-infected people have latent TB (LTB) 
and remain asymptomatic, they have a 10% lifetime risk of devel-
oping active TB (ATB). Mtb infection induces a potent T helper 
type 1 (Th1) immune response in the host, which contributes to 
protective immunity (2). Interestingly, helminth parasites, which 
characteristically elicit Th2 responses (3, 4), are endemic in the 
populations where TB prevalence is highest (5). Approximately 
1 billion people are infected with one or more helminths, of which 
schistosomiasis, caused by trematodes of the genus Schistosoma 
mansoni (S. mansoni), affects about 207 million individuals (6). 
Human studies on coinfected individuals suggest that infection 
with helminths compromise protection conferred by M. bovis 
Bacillus Calmette-Guerin (BCG) vaccination (7–9) and may be 
associated with increased TB reactivation rates in HIV-infected 
patients (10). In experimental models, mice chronically infected 
with S. mansoni have increased susceptibility to M. bovis BCG sys-
temic infection, accompanied by decreased M. bovis BCG–specific 
Th1 responses (11). Additionally, S. mansoni–infected mice vacci-
nated with M. bovis BCG demonstrate reduced protection upon 
subsequent Mtb systemic challenge (12). Thus, the prevailing 
models suggest that Th2 responses induced due to helminth coin-
fections impair Th1 immune responses and Mtb control.
Using a mouse model of Mtb infection, we show that coin-
fection with a helminth, such as S. mansoni, or immunization 
with S. mansoni–derived egg antigens can reversibly impair Mtb- 
specific Th1 cell responses without severely affecting the ability 
of the macrophages to limit Mtb control. Importantly, S. mansoni 
infection results in accumulation of arginase-1–expressing mac-
rophages in the lung, forming type 2 granulomas and resulting 
in increased lung fibrosis and mucous plug formation, and exac-
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high arginase-1–expressing macrophages were distinct (55% of 
granulomas) and in close proximity to type 1 granulomas (45% 
of granulomas) typically containing macrophages expressing 
high inducible nitric oxide synthase (iNOS) (Figure 1, C and D), 
while no type 2 granulomas were observed in Mtb-infected lungs. 
In addition, arginase-1–expressing macrophages were also local-
ized within the lung interstitium of S. mansoni/Mtb–coinfected 
mice but not in the lungs of Mtb-infected mice (Figure 1, C and 
D). Interestingly, mice infected with S. mansoni alone also exhib-
ited increased inflammation (Supplemental Figure 1B), when 
compared with either uninfected lungs or Mtb-infected lungs and 
exhibited increased accumulation of arginase-1–expressing mac-
rophages (Figure 1C, Supplemental Figure 1C). F4/80-expressing 
macrophages (Figure 1C) — and not T cells, B cells, or eosinophils 
— were the predominant expressors of arginase-1 within the tuber-
cle granulomas in the lungs of coinfected mice (Supplemental 
Figure 1D). Furthermore, using Yarg-coinfected mice, we found 
that lung macrophages — but not neutrophils, eosinophils, or lym-
phocytes — were the major producers of arginase-1 in coinfected 
mice (Supplemental Figure 1E). Purified lung macrophages also 
expressed higher arginase-1 mRNA levels when compared with 
neutrophils isolated from coinfected mice (Supplemental Figure 
1F). Together, these data demonstrate that S. mansoni infection 
results in accumulation of arginase-1–expressing macrophages 
in the lung and, upon infection with Mtb, promotes exacerbated 
inflammation and increased TB disease severity.
Coincident with increased accumulation of arginase-1–
expressing macrophages, we also found increased expression of 
Th2 cytokines such as Il4 and Il13 mRNA in the lungs of S. man-
soni/Mtb–coinfected mice (Figure 2A). This also coincided with 
increased expression of mRNA for matrix metalloproteases, 
such as Mmp13, and neutrophil-derived products, such as mye-
loperoxidases (Mpo), in S. mansoni/Mtb–coinfected lungs (Figure 
2A). Furthermore, lungs from S. mansoni/Mtb–coinfected mice 
showed increased numbers of Muc5AC+ goblet cells, increased 
staining for mucins and glycogen in Periodic acid-Schiff–stained 
(PAS-stained) lung sections, and increased collagen deposition 
within type 2 granulomas (Figure 2B). These data together suggest 
that helminth infection drives accumulation of high arginase-1–
expressing macrophages inside type 2 granulomas and interstitial 
areas, induces mucus production and local fibrosis, and exacer-
bates pulmonary inflammation in Mtb-coinfected mice.
Our recent studies have demonstrated that, in TB, protective 
granulomas contain distinct B cell lymphoid follicles harboring 
T cells and macrophages, while inflammatory granulomas lack 
well-formed B cell–containing lymphoid follicles and instead 
contain neutrophils that mediate inflammation (13, 14). Thus, we 
next measured the area occupied by lymphoid B cell follicles and 
found that S. mansoni coinfection in Mtb-infected mice resulted 
in decreased and poorly formed B cell follicles (Figure 2C). Con-
sistent with reduced B cell follicle formation, we also found that 
T cell accumulation was decreased within the lymphoid follicles, 
and T cells instead formed perivascular cuffs (Figure 2D). These 
data suggest that the majority of granulomas formed in S. man-
soni/Mtb–coinfected lungs are preferentially composed of granu-
locytes and loosely organized B cell lymphoid follicles, a feature 
associated with nonprotective inflammatory granulomas (13).
erbating disease severity and inflammation in Mtb-coinfected 
mice. These inflammatory effects are mediated by macrophages 
expressing arginase-1 and can be reversed by treatment with anti-
helminthics. Our recent work has put forth the new paradigm that 
protective outcomes in TB are associated with formation of lym-
phoid follicles within the tubercle granuloma (13), while increased 
disease severity is associated with accumulation of neutrophils 
and exacerbated inflammation (14). We show that an outcome 
of S. mansoni infection and the induction of type 2 granulomas 
within the Mtb-infected lung is the reduced formation of lymphoid 
follicle–containing granulomas in helminth/Mtb–coinfected hosts 
and increased accumulation of inflammatory granulocytes. In 
addition, using Mtb-infected genetically diverse mice, which 
exhibit heterogeneity in inflammation and disease severity (14), 
we demonstrate that exacerbated lung inflammation — even in the 
absence of helminth coinfection — is associated with increased 
arginase-1 activity. Importantly, increased arginase-1 activity in 
the serum of patients with ATB is associated with exacerbated 
lung inflammatory damage and disease severity. Increased argi-
nase-1 activity detected in the serum from helminth-coinfected 
ATB patients when compared with ATB patients without hel-
minth coinfections further substantiates our findings. Thus, our 
data together put forth the hypothesis that helminth coinfection 
or exposure to helminth antigens increases TB susceptibility and 
disease severity by induction of arginase-1–expressing macro-
phages and formation of inflammatory granulomas, rather than 
just impairing Th1 responses and Mtb control. These data provide 
insights into the mechanisms by which helminth coinfections 
increase susceptibility, accelerate disease progression, and facil-
itate reactivation of TB.
Results
S. mansoni coinfection induces lung fibrosis and exacerbates inflam-
mation during TB. Although helminth coinfections are thought to 
increase susceptibility to Mtb infection, the mechanisms underly-
ing this association remain poorly understood. To experimentally 
model helminth and Mtb coinfection, we infected C57BL/6 argin-
ase-1 yellow fluorescent protein (YFP) reporter mice (Yarg mice) 
with S. mansoni and allowed helminth infection to progress for 
6 weeks, a period associated with induction of potent Th2 
responses (15). Following this, mice were infected with low doses 
of aerosolized Mtb, and TB disease progression was monitored. 
Mice coinfected with S. mansoni and Mtb had larger inflammatory 
granulomas in the lungs (Figure 1A and Supplemental Figure 1A, 
upper panel; supplemental material available online with this arti-
cle; doi:10.1172/JCI77378DS1), which contained both eosinophils 
and neutrophils (Supplemental Figure 1A, lower panel). In con-
trast, smaller and more lymphocytic granulomas were detected in 
the lungs of Mtb-infected mice (Figure 1A and Supplemental Fig-
ure 1A). The increased inflammatory response coincided with a 
significant increase in the number of arginase-1–expressing mac-
rophages in S. mansoni/Mtb–coinfected mice, when compared 
with Mtb-infected mice (Figure 1B). In addition, increased pulmo-
nary mRNA expression for Arg1, and increased arginase-1 activity 
in the serum of S. mansoni/Mtb–coinfected mice was detected, 
when compared with Mtb-infected mice (Figure 1B). Interestingly, 
in coinfected lungs, we found that type 2 granulomas containing 
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in Th1 responses ex vivo coincided with a significant but slight 
increase in lung Mtb burden in S. mansoni/Mtb–coinfected mice 
when compared with Mtb-infected mice (Figure 2I). Unexpect-
edly, our data thus suggest that the Th2 responses induced by 
helminth infection have reversible effects on Th1 immunity and 
minimal effect on mycobacterial control, but they more promi-
nently affect lung inflammation.
Treatment of S. mansoni/Mtb–coinfected mice with an antihel-
minthic can reverse TB disease severity. Praziquantel is an antihel-
minthic used for treatment of human schistosomiasis (17). Thus, 
we next addressed if treatment with an antihelminthic such 
as praziquantel can be used to limit disease severity in S. man-
soni/Mtb–coinfected mice. Mice were infected with S. mansoni 
and coinfected with Mtb, following which one group was treated 
with praziquantel while the control coinfected group was treated 
with PBS. Treatment with praziquantel resulted in significantly 
decreased S. mansoni egg burden in the liver (Supplemental Figure 
S. mansoni coinfection reversibly impairs Th1 responses and lim-
its Mtb bacterial control. Accumulation of IFN-γ–expressing Th1 
cells is critical for protective immunity against Mtb infection (16). 
We found that accumulation of IFN-γ–producing activated CD4+ 
T cells was impaired in S. mansoni/Mtb–coinfected lungs (Figure 
2E), and this coincided with a trend in the increase in IL-4–pro-
ducing CD4+ T cells (Figure 2F) and no differences in accumu-
lation of Foxp3-expressing Tregs (data not shown). In addition, 
the impaired Th1 response was associated with decreased acti-
vation of macrophages, as measured by MHC Class II (MHCII) 
expression (Figure 2G). Interestingly, the small but significant 
impairment in production of IFN-γ by lung CD4+ T cells in S. 
mansoni/Mtb–coinfected mice (Figure 2E) was reversible, as the 
number of Mtb-specific IFN-γ–producing CD4+ T cells measured 
by in vitro overnight antigen–driven ELISpot assay was compara-
ble between S. mansoni/Mtb–coinfected mice and Mtb-infected 
mice (Figure 2H). Furthermore, we found that the impairment 
Figure 1. S. mansoni induces arginase-1–expressing type 2 granulomas and exacerbates inflammation during coinfection with Mtb. S. mansoni–
infected (Mtb + Sm) or control Yarg mice (Mtb) were aerosol infected with Mtb. (A) On d30 after infection, pulmonary inflammation was assessed on 
formalin-fixed, paraffin embedded (FFPE) lung sections stained with H&E. Magnification: ×100. Total area occupied by inflammatory lesions per lobe 
was quantified. (B) Arginase-1 reporter expression in lung macrophages was detected by flow cytometry (left panel). Arg1 mRNA expression in total lung 
was assessed by RT-PCR and expression relative to Gapdh expression shown (middle panel). Arginase-1 activity was quantitated in the serum of infected 
mice (right panel). (C) FFPE sections from infected mice underwent immunofluorescence staining using antibodies specific for arginase-1, iNOS, and 
F4/80. Mosaics (4×4) of ×200 magnification fields are shown. Type 1 granulomas (red selection), type 2 granulomas (green selection), and interstitial 
macrophages (arrows) are shown. (D) The number of high iNOS+ and high arginase-1–expressing F4/80+ cells per ×200 field were counted, and ratio of high 
arginase-1–expressing cells to high iNOS-expressing cells per field is shown. n = 4–5 mice per group. Lungs of all mice were included in the analysis; one 
representative image per group is shown. *P ≤ 0.05, ***P ≤ 0.001, ****P ≤ 0.0001 unpaired; 2-tailed Student’s t test (A and B) or 1-way ANOVA with post-
hoc Tukey (D) were used. Results are representative of 3 independent experiments.
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nary granulomas (Supplemental Figure 2B), decreased staining for 
Muc5AC+ goblet cells, and decreased accumulation of mucins and 
glycogen (Supplemental Figure 2, C and D). The decreased inflam-
mation in praziquantel-treated coinfected mice coincided with a 
reduction in serum arginase-1 activity (Figure 3C) and decreased 
accumulation of high arginase-1–expressing macrophages within 
2A). As before, S. mansoni/Mtb–coinfected control mice exhibited 
increased disease severity (Figure 3, A and B) and increased col-
lagen deposition (Supplemental Figure 2B), when compared with 
Mtb-infected mice. Importantly, coinfected mice treated with 
praziquantel significantly reversed exacerbated inflammation 
(Figure 3, A and B), decreased collagen deposition within pulmo-
Figure 2. S. mansoni coinfection leads to increased lung pathology, impaired Th1 responses, and increased susceptibility to Mtb infection. S. mansoni– 
infected (Mtb + Sm) or control Yarg mice (Mtb) were infected with Mtb. (A) On d30 after infection, lung expression of Il4, Il13, Mmp13, and Mpo mRNA 
relative to Gapdh was determined by RT-PCR. (B) Formalin-fixed, paraffin embedded (FFPE) sections were processed for immunofluorescence using 
antibodies for Muc5AC and CD3; mucus and glycogen accumulation by the PAS stain and collagen deposition by Gomori’s Trichrome stain are shown. 
Magnification: ×200. Arrows indicate areas of positive staining. (C–D) Immunofluorescence staining for B220 and CD3 was also performed. Magnification: 
×200. The average size of B cell follicles within granulomas (C) and the average area of perivascular T cell cuffing (D) were calculated. (E–F) The percentage 
of lung IFN-γ– (E) and IL-4–producing activated T cells (CD4+CD44+IFN-γ+ and CD4+CD44+IL-4+, respectively) (F) were determined by flow cytometry. (G) 
MHCII expression on lung macrophages was determined by flow cytometry. (H) The percentage of ESAT-61–20–specific, IFN-γ–producing cells in the lungs 
was determined by antigen-driven ELISpot. (I) Lung bacterial burden was determined by plating. n = 4–9 mice per group. Lungs of all mice were included in 
the analysis; one representative image per group is shown. #P = 0.0616, *P ≤ 0.05, ***P ≤ 0.001; unpaired, 2-tailed Student’s t test (A and C–I). Results are 
representative of 2 independent experiments.
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Arginase-1 expression drives exacerbated inflammation in hel-
minth/Mtb–coinfected hosts. Our data thus far suggest that S. man-
soni infection induces the accumulation of arginase-1–express-
ing macrophages within the lung, which mediate exacerbated 
inflammation and increased TB disease upon Mtb infection. To 
mechanistically address if arginase-1 expression in macrophages 
mediates the exacerbated disease seen in helminth/Mtb–coin-
fected mice, we then generated BM chimeric mice (BMC mice). 
the type 2 granulomas in the lungs (Figure 3, D and E). This also 
coincided with increased activation of lung macrophages (Figure 
3F) and improved Mtb control (Figure 3G) in praziquantel-treated 
coinfected mice when compared with control coinfected mice. 
Together, these data provide formal evidence that use of antihel-
minthics can reverse the accumulation of arginase-1–expressing 
macrophages in the lung to prevent exacerbated inflammation 
and decrease disease severity in S. mansoni/Mtb–coinfected hosts.
Figure 3. Praziquantel treatment of S. mansoni infection reverses the increased inflammation seen in Mtb/S. mansoni–coinfected mice. S. mansoni–
infected (Mtb + Sm) or control C57BL/6 mice (Mtb) were aerosol infected with Mtb and treated with praziquantel (Mtb + Sm + PZQ). (A) On d30 after infec-
tion, pulmonary inflammation was assessed on formalin-fixed, paraffin embedded (FFPE) lung sections stained with H&E. Magnification: ×200. (B) Total 
area occupied by inflammatory lesions per lobe was quantified. (C) Arginase-1 activity was quantitated in the serum of infected mice. (D) FFPE sections 
from infected mice underwent immunofluorescence staining using antibodies specific for arginase-1, iNOS, and F4/80. Mosaics (4×4) of ×200 magnifi-
cation fields are shown. Type 1 granulomas (red selection), type 2 granulomas (green selection), and interstitial macrophages (arrows) are shown. (E) The 
number of high arginase-1–expressing F4/80+ cells per ×200 field was determined. (F) MHCII expression on lung macrophages was determined by flow 
cytometry. (G) Lung bacterial burden was determined by plating. n = 4–5 mice per group. Lungs of all mice were included in the analysis; one representative 
image per group is shown. **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001; one-way ANOVA with post-hoc Tukey (B, C, and E–G).
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The Tie2-Cre deleter is active in all hematopoietic cells, but as 
arginase-1 is predominantly expressed in macrophages in TB 
and schistosomiasis (18, 19), use of Tie2-Cre Arg1fl/fl BM cells for 
reconstitution of BMC will delete arginase-1 in macrophages 
(18–22). In addition, as only BM myeloid cells lacking arginase-1 
were transferred, any effects of host-derived endothelial argin-
ase-1 are avoided. Thus, C57BL/6.SJL host mice received either 
WT BM (WT BMC-Arg1fl/fl) or BM from arginase-1–deficient mice 
where myeloid cells, including macrophages, are devoid of argin-
ase (Tie2-Cre Arg1fl/fl BMC) (18). Upon confirmation of complete 
reconstitution, BMC mice were infected with S. mansoni, followed 
by coinfection with Mtb as before. Under these conditions, both 
WT BMC and Tie2-Cre Arg1fl/fl BMC–coinfected mice exhibited 
a slight but significant increase in bacterial burden when com-
pared with Mtb-infected WT BMC mice (Figure 4A). In contrast, 
Tie2-Cre Arg1fl/fl BMC–coinfected mice exhibited decreased lung 
inflammation (Figure 4, B and C), increased formation of pro-
tective B cell follicles within TB granulomas (Figure 4D), and 
decreased T cell perivascular cuffing when compared with WT 
BMC-coinfected mice (Figure 4E). This coincided with the com-
plete absence of arginase-1–expressing macrophages within the 
lungs of Tie2-Cre Arg1fl/fl BMC–coinfected mice, when compared 
with accumulation of high arginase-1–expressing macrophages in 
lungs of WT BMC-coinfected mice (Figure 4F). To provide addi-
tional confirmation that macrophages are the primary producers 
of arginase-1 in coinfected mice, we also generated BMC mice 
where C57BL/6.SJL host mice received either WT BMC-Arg1fl/fl 
or BM from Lysm-Cre Arg1fl/fl mice (deletes in monocytes, mac-
rophages, and neutrophils). As before (18), while macrophages 
generated from BM cells from Tie2-Cre Arg1fl/fl mice expressed no 
detectable arginase-1 protein, macrophages generated from BM 
cells from Lysm-Cre Arg1fl/fl mice expressed substantially reduced 
levels of arginase-1 expression (Supplemental Figure 3, A and B). 
However, similar to the Tie2-Cre Arg1fl/fl BMC–coinfected mice, the 
Lysm-Cre Arg1fl/fl BMC–coinfected mice also demonstrated higher 
bacterial burden (Supplemental Figure 4A). In addition, also sim-
Figure 4. Absence of arginase-1 in lung macrophages reverses lung pathology upon coinfection. WT BMC or Tie2-Cre Arg1fl/fl BMC mice were S. mansoni/
Mtb coinfected (Mtb + Sm) or infected with Mtb alone (Mtb). (A) On d25 after infection, lung bacterial burden was determined by plating. (B) Pulmonary 
inflammation was assessed on formalin-fixed, paraffin embedded (FFPE) lung sections stained with H&E. Magnification: ×100. (C) Total area occupied 
by inflammatory lesions per lobe was quantified. (D) FFPE sections were processed for immunofluorescence using antibodies for B220 and CD3. Mag-
nification: ×200. The average size of B cell follicles within granulomas was determined. (E) The average area of perivascular T cell cuffing in B220- and 
CD3-stained sections was calculated. (F) FFPE sections were stained with antibodies specific for arginase-1, iNOS, and F4/80. Magnification: ×200. The 
number of high arginase-1–expressing F4/80+ cells per ×200 field was determined. n = 3–10 mice per group. Lungs of all mice were included in the analysis; 
one representative image per group is shown. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. ND, not detectable. One-way ANOVA with post-hoc Tukey (A and C) and 
unpaired, 2-tailed Student’s t tests were used (D–F).
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ilar to the Tie2-Cre Arg1fl/fl BMC–coinfected mice, Lysm-Cre Arg1fl/fl 
coinfected BMC exhibited decreased inflammation (Supplemen-
tal Figure 4, B and C), and this coincided with improved B cell fol-
licle formation, reduced perivascular T cell cuffing, and reduced 
accumulation of arginase-1–expressing macrophages within the 
granulomas (Supplemental Figure 4, D–F). As macrophages and 
not neutrophils are the predominant producers of arginase-1 in 
coinfected mice (Supplemental Figure 1, E and F), these results 
provide direct evidence that accumulation of arginase-1–express-
ing macrophages in the lungs following S. mansoni infection medi-
ates exacerbated inflammation and disease severity during Mtb 
coinfection, without affecting mycobacterial control.
SEA immunization exacerbates lung inflammation during Mtb 
infection. In addition to the generation of type 2 granulomas, S. 
mansoni coinfection in Mtb-infected mice may also alter tissue 
architecture due to the physical presence of the parasite and, thus, 
exacerbate lung pathology. Therefore, we sought to determine 
whether exposure to the helminth product S. mansoni egg anti-
gen (SEA), which contains the major antigens that induce Th2 
responses during infection (15), is by itself sufficient to exacer-
bate lung inflammation in TB. Thus, C57BL/6 mice were aerosol 
infected with low doses of Mtb and were immunized with SEA at 
day 15 after infection, a time when Mtb-specific T cell responses are 
initiated in the mouse model of TB (23). We found that mice that 
were SEA immunized and Mtb infected demonstrated increased 
lung inflammation (Figure 5A), and type 1 granulomas harbored 
fewer iNOS-expressing macrophages (Figure 5B). In contrast to 
S. mansoni/Mtb–infected lungs, we did not observe distinct argin-
ase-1–expressing macrophage containing type 2 granulomas in the 
lungs of SEA-immunized Mtb-infected mice (data not shown) but 
nevertheless found increased expression of Arg1 mRNA in sorted 
lung CD11c+ cells from SEA-immunized Mtb-infected mice (Fig-
ure 5C). Similarly, we found that the formation of B cell follicles 
was reduced and less organized in SEA-immunized Mtb-infected 
mice (Figure 5D), and this coincided with decreased accumulation 
of T cells within lymphoid follicles, which instead accumulated as 
T cell perivascular cuffs (Figure 5E). Importantly, mice similarly 
immunized with a control antigen such as BSA or a Th1 promoting 
antigen such as purified protein derivative (PPD) did not promote 
lung inflammation, instead limiting inflammation (Supplemen-
tal Figure 5, A and B). In addition, mice immunized with either 
BSA or PPD did not affect Mtb burden (Supplemental Figure 5C). 
Together, these data suggest that exacerbated lung inflammation 
and decreased formation of protective B cell follicles can be reca-
pitulated by immunization with SEA in Mtb-infected mice, suggest-
ing that the inflammatory effects of the coinfection are due to the 
presence of Schistosoma antigens and likely not due to tissue altera-
tions caused by the physical presence of the helminth parasite.
Figure 5. SEA immunization increases 
susceptibility to Mtb infection. C57BL/6 
mice were aerosol infected with Mtb 
and immunized with SEA (Mtb + SEA) 
or saline (Mtb) on d15 after infection. (A) 
Pulmonary inflammation was assessed 
on d30 after infection on H&E-stained 
formalin-fixed, paraffin embedded 
(FFPE) lung sections. Magnification: 
×40. Total area occupied by inflamma-
tory lesions per lobe was quantified. 
(B) FFPE sections from infected lungs 
were processed for immunofluorescence 
using antibodies specific for iNOS and 
F4/80, and the number of iNOS-
expressing F4/80+ cells per 200× field 
was counted. (C) CD11c+ cells were sorted 
from the lungs of SEA-treated Mtb- 
infected mice and Mtb-infected mice, 
and level of Arg1 mRNA relative to 
Gapdh was determined by RT-PCR. (D–E) 
FFPE lung sections were also stained 
using antibodies specific for B220 and 
CD3. Magnification: ×200. The average 
size of B cell follicles within granulo-
mas (D) and the average area occupied 
by perivascular T cell cuffing (E) were 
calculated. n = 4–8 mice per group. 
Lungs of all mice were included in the 
analysis; one representative image per 
group is shown. *P ≤ 0.05, ***P ≤ 0.001; 
unpaired, 2-tailed Student’s t test. 
Results are representative of 2 indepen-
dent experiments.
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cytokines Il4, Il5, and Il13 was below the threshold of detection. 
To further address if the inhibition of IFN-γ production occurs in 
Mtb-specific Th cells, we adoptively transferred naive CD4+ T cells 
isolated from the Mtb early secretory antigenic target 6 (ESAT-6) T 
cell receptor (TCR) transgenic (Tg) mice into Cd4–/– mice, infected 
the mice with low doses of aerosolized Mtb, and isolated in vivo 
expanded Th cells from the lungs on day 30 after infection. Con-
sistent with our previous data, these isolated Th cells produced 
IFN-γ upon restimulation with ESAT-6, but in vitro SEA treatment 
in the presence of APCs inhibited the production of IFN-γ (Figure 
6C) without inducing detectable levels of IL-4 (data not shown).
Next, we assessed whether, similar to Schistosoma infection, 
SEA immunization affects Th1 immunity in vivo. We found that 
total IFN-γ levels in lung homogenates were reduced in SEA- 
immunized Mtb-infected mice when compared with Mtb-infected 
lungs (Figure 6D). Next, to assess the effect of SEA at the cellu-
lar level, using IFN-γ reporter mice (Yeti mice), we found that 
SEA immunization decreased both the accumulation of activated 
SEA-mediated inhibition of Th1 responses in Mtb infection is 
reversible. Aerosol infection of mice with Mtb results in a chronic 
pulmonary infection that induces a predominantly Th1 immune 
response in the lung (23). Consistent with this, we found that 
CD4+ T cells isolated from the lungs of chronically Mtb-infected 
WT C57BL/6 mice strongly expressed mRNA for Ifng, Tnf, Stat1, 
and Il12rb2, which are associated with the Th1 cell pathway (Sup-
plemental Table 1), but not canonical Th2 (Gata3, Il4ra) or Th17 
genes (Il17a, Rorc). In vitro treatment of such isolated CD4+ T cells 
with SEA in the presence of irradiated APCs inhibited both poly-
clonal (anti–CD3/CD28 bead stimulated) and Mtb-specific IFN-γ 
production (Figure 6A), without detectable IL-4 production in cul-
ture supernatants (data not shown). Upon analysis of gene expres-
sion in these cell pellets, we found genes associated with Th1 func-
tion (Ifng, Tbx21, and Cxcr3), T cell signaling (Lck, Cd3g, Zap70, 
and Lat), T cell costimulation (Cd40lg, Icos, and Cd28), and T cell 
activation (Il2ra) were downregulated in SEA-treated cells (Sup-
plemental Table 2 and Figure 6B), while expression of the Th2 
Figure 6. SEA treatment impairs Mtb-driven Th1 responses and increases susceptibility to Mtb infection. (A) Lung CD4+ cells were purified from d30 
Mtb-infected mice and incubated with Schistosoma egg antigen (Mtb + SEA) or without SEA (Mtb) and APCs. Cells were restimulated with α-CD3/CD28 
beads or irradiated splenocytes, and ESAT-61–20 peptide and supernatant IFN-γ levels were assessed. (B) Overall gene-expression changes induced by SEA 
in cell pellets from A were assessed by RNAseq. Heat-map representation of significant genes is shown. (C) CD4+ cells sorted from ESAT-6 TCR Tg mice 
were transferred to Cd4–/– mice, which were Mtb infected. On d30 after infection, lung CD4+ cells were sorted, treated with SEA, and restimulated with 
irradiated splenocytes and ESAT-61–20 peptide. Supernatant IFN-γ levels were determined. (D) In some experiments, Mtb-infected C57BL/6 mice were 
immunized with SEA or saline on d15 after infection. Lung IFN-γ levels from d30 were determined. (E) Mtb-infected Yeti mice were immunized with SEA 
on d15 after infection, and the percentage of lung CD4+CD44+YFP+ cells was determined by flow cytometry. (F) IFN-γ MFI (YFP) within CD4+CD44+ T cells 
was determined. (G) The number of lung ESAT-61–20–specific, IFN-γ–producing cells was determined by ELISpot. (H) Lung CD4+CD44+IFN-γ+ cell numbers 
following PMA/ionomycin stimulation were determined. (I) C57BL/6 mice were infected with Mtb and immunized with SEA or saline on d1, d15, or both d1 
and d15 after infection, and d30 lung bacterial burden was determined. n = 3 samples (A and B) or n = 5–9 mice (C–I). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, 
****P ≤ 0.0001; 1-way ANOVA with post-hoc Tukey (A, E, F, G, and I) or unpaired, 2-tailed Student’s t test (C, D, and H) were used. One experiment of 2 
shown. Un, uninfected controls.
The Journal of Clinical Investigation   R e s e a R c h  a R t i c l e
4 7 0 7jci.org   Volume 125   Number 12   December 2015
with increased susceptibility to TB, suggesting that the presence of 
SEA during initiation of Mtb-specific T cell responses, but not ear-
lier, affects protective outcomes during Mtb infection (Figure 6I).
In vitro SEA-treated CD4+ T cells from Mtb-infected lungs 
that demonstrated impaired T cell activation and IFN-γ produc-
tion (Figure 6, A and B) — upon subsequent washes to remove SEA 
and further incubation with Mtb-infected alveolar macrophages 
— could now produce IFN-γ and activate macrophages to induce 
iNOS (Supplemental Figure 6, A and B), which coincided with con-
trol of Mtb infection in infected alveolar macrophages, albeit not 
to the same level as CD4+ T cells isolated from Mtb-infected lungs 
(Supplemental Figure 6C). Not surprisingly, naive lung CD4+ T 
cells isolated from uninfected mice, which demonstrated poor 
induction of IFN-γ production in T cells (Supplemental Figure 
6A) and decreased induction of iNOS (Supplemental Figure 6B), 
exhibited reduced Mtb control in alveolar macrophages (Supple-
mental Figure 6C). These data together with the improved Mtb 
control observed in praziquantel-treated coinfected mice (Figure 
3G) indicate that, although the presence of helminth antigens is 
sufficient to dampen Mtb-specific Th1 responses, these effects are 
reversible upon removal of the parasite and/or its products.
IFN-γ–producing CD4+ T cells in Mtb-infected animals (Figure 6E) 
and levels of IFN-γ reporter expression by activated CD4+ Th cells 
in the lungs of Mtb-infected mice (Figure 6F). Strikingly, assess-
ment of IFN-γ Mtb-specific T cell responses by restimulation 
with Mtb antigen in ELISpot assays, or following stimulation with 
PMA/Ionomycin, showed no differences between SEA-treated 
and Mtb-infected groups (Figure 6, G and H). These data together 
suggest that SEA-mediated inhibition of IFN-γ expression in CD4+ 
T cells evident in vitro (in cultured Th cells with SEA and APCs) 
and ex vivo (as assessed by reporter expression) can be reversed by 
in vitro culture in the absence of SEA (as assessed by ELISpot and 
intracellular staining). These data suggest that the effects of SEA 
on Th cell cytokine production and activation profile can be potent 
in in vitro cultures, but the effects are reversible upon removal of 
SEA. Additionally, activation of lung macrophages as measured 
by MHCII expression was reduced in SEA-treated Mtb-infected 
mice (data not shown). Incidentally, decreased Th1 responses 
and decreased macrophage activation coincided with a small but 
significant increase in bacterial burden in the lungs of SEA-immu-
nized Mtb-infected mice (Figure 6I). Interestingly, immunization 
with SEA on day 15 but not day 1 in Mtb-infected mice coincided 
Figure 7. Arginase-1 expression during Mtb 
infection in genetically diverse mice and in 
humans correlates with increased inflamma-
tion and lung damage. Individual DO (n = 40) 
mice were aerosol infected with Mtb, and lung 
bacterial burden on d50 after infection was 
determined. Total area occupied by inflammatory 
lesions per lobe was quantified in H&E-stained 
formalin-fixed, paraffin embedded (FFPE) lung 
sections. RNAseq was performed on lung RNA 
from individual DO mice with the most SI and 
individual DO mice with EC, which also correlated 
with improved formation of lymphoid follicles 
within the granulomas. (A) Heat-map represen-
tation of significant genes. (B) The levels of Arg1 
mRNA expression relative to Gapdh in lungs of 
individual DO mice with SI or EC was determined 
by RT-PCR. (C) Arginase-1 activity was deter-
mined in lung homogenates of individual DO, 
and linear correlation between arginase-1 activity 
and lung inflammatory area was determined 
(Pearson’s correlation, log2 scale). (D) Linear cor-
relation analysis of arginase-1 activity in serum 
of patients with ATB and their lung damage 
score was carried out (Pearson’s correlation,  
n = 13). (E) The levels of ARG1 mRNA expression 
relative to GAPDH in blood monocyte cDNA 
derived from LTB (n = 5) and ATB (n = 6) human 
donors were determined. (F) Arginase-1 activity 
in serum from ATB patients with helminth coin-
fection and those without helminth coinfections 
was measured (n = 22 each). *P ≤ 0.05; unpaired, 
2-tailed Student’s t test (B, E, and F) was used.
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Th1 responses, arginase-1 may have a new emerging role to play in 
mediating pulmonary inflammation in TB.
Discussion
TB remains one of the largest global health threats, and it is esti-
mated that 5%–10% of infected individuals are likely to progress 
to ATB. However, the mechanisms leading to TB reactivation in 
otherwise immunocompetent individuals are largely undefined. 
As such, coinfection with helminths is considered a risk factor 
associated with increased TB reactivation rates and increased 
susceptibility to TB. However, thus far, the mechanisms behind 
this association remain poorly defined. In this study, we demon-
strate that coinfection with S. mansoni, or presence of S. man-
soni products such as SEA, can reversibly impair Th1 immune 
responses, but its effects on Mtb control are minimal. Unexpect-
edly, our data demonstrate that the more prominent effect of hel-
minth infection during TB is the accumulation of high arginase-1–
expressing macrophages within type 2 granulomas in the lung, 
mediating exacerbated inflammation and lung pathology during 
coinfection. Importantly, the effects driven by helminth-induced 
arginase-1–expressing macrophages on inflammation are revers-
ible, as treatment with antihelminthics can improve TB disease 
outcome. Our data in genetically diverse DO mice infected with 
Mtb and humans with ATB also show that increased arginase-1 
activity correlates with increased inflammatory damage and dis-
ease severity during TB. Furthermore, helminth coinfection in 
ATB patients increases arginase-1 activity in serum. Together, 
our data suggest that, contrary to the well-known antiinflamma-
tory role for arginase-1 and its inhibitory effects on Th1 responses 
(26), arginase-1 has a new prominent role in driving inflammation 
and mediating lung damage during TB.
Evidence suggests that a skewed Th2 response caused due 
to S. mansoni infection compromises protection conferred by M. 
bovis BCG vaccination in humans (7–9) and in mice systemically 
infected with Mtb (12). Similarly, other models of helminth coin-
fections such as Nippostrongylus brasiliensis, a rodent intestinal 
helminth that migrates to the lung, also drives Th2 responses and 
generation of alternatively activated macrophages in the lung, 
resulting in impaired resistance to Mtb (27). Interestingly, while 
helminth coinfections increase M. bovis BCG (11) and Mtb (27) 
lung burden, the increase in mycobacterial burden is often tran-
sient (27) and moderate (about 1 log higher in coinfected hosts) 
(11, 27), suggesting that the effect of helminth coinfections on 
Mtb control is not profound enough to fully explain the increased 
severity of TB in helminth-coinfected individuals observed in TB 
endemic regions. Furthermore, in some models of helminth/Mtb 
coinfection, there are no differences observed in overall mycobac-
terial control (28, 29). Our results support these published stud-
ies, as S. mansoni coinfection or immunization with SEA resulted 
in increased Mtb burden in the lung. However, this effect was not 
profound, suggesting that Mtb control mechanisms are not com-
pletely suppressed in coinfected hosts. Furthermore, while some 
evidence suggests that Mtb-specific Th1 responses are impaired 
due to helminth coinfection (7, 11, 30), other studies have found 
that Mtb-specific Th1 responses are unaltered in the presence of 
helminth infections (27, 29). Our studies show that Mtb infection 
induces a potent Th1 signature in in vivo primed T cells isolated 
Helminth infections are associated with increased TB reacti-
vation rates in HIV-infected patients (10). Thus, based on our data 
that S. mansoni infection or immunization with SEA can exacerbate 
lung inflammation and increase Mtb susceptibility, we then tested 
whether SEA immunization would affect disease progression in 
mice undergoing TB reactivation. Using the Cornell model of Mtb 
reactivation (24), chronically Mtb-infected mice were treated with 
isoniazid and rifampicin until no cultivable lung bacteria were 
recovered (14), and mice were immunized with SEA and sponta-
neously allowed to reactivate Mtb infection. We found that SEA- 
immunized mice had higher lung and spleen bacterial burden when 
compared with control mice that also reactivated Mtb infection 
(Supplemental Figure 7). These data, for the first time to our knowl-
edge, provide experimental evidence that TB reactivation can be 
accelerated due to the presence of helminth products such as SEA, 
likely due to its effect on both Th1 responses and due to decreased 
formation of lymphoid follicle–containing lung granulomas.
Arginase-1 expression is associated with exacerbated inflam-
mation in TB. Our data demonstrate that arginase-1 induced in 
response to S. mansoni infection and SEA immunization exacer-
bates inflammation in inbred C57BL/6 Mtb-infected mice. Inbred 
mice do not exhibit the heterogeneity in inflammatory responses 
seen in human TB. Thus, we recently used the diversity outbred 
(DO) mouse population to model heterogeneity in lung inflam-
matory and protective outcomes upon Mtb infection (14). We next 
addressed if arginase-1 expression in Mtb-infected DO hosts, even 
in the absence of helminth coinfection, was associated with exac-
erbated lung inflammation. Thus, we carried out RNA sequencing 
on lungs of individual genetically diverse DO mice that had severe 
inflammation (SI) and compared their transcriptional expression 
profile to individual DO mice that had enhanced control (EC), 
which coincided with formation of lymphoid follicle–containing 
granulomas and decreased Mtb burden (14). Interestingly, we 
found that Arg1 mRNA was among the top 10 genes differentially 
expressed in mice with SI, when compared with genes expressed 
in lungs of mice with enhanced Mtb control (Supplemental Table 
3 and Figure 7A). In support of recently published studies (14, 25), 
mRNA for inflammatory molecules such as S100a8 and S100a9, 
and chemokines associated with neutrophilic accumulation, were 
also increased in the lungs of mice with SI at the mRNA level (Sup-
plemental Table 3). The increased expression of Arg1 mRNA was 
confirmed by RT-PCR (Figure 7B). Importantly, arginase-1 activ-
ity in lung homogenates of individual DO mice correlated with 
increased pulmonary inflammation (Figure 7C). Thus, we then 
addressed whether arginase-1 could be an inflammatory marker 
that correlates with the extent of lung damage in human ATB 
patients in a TB endemic setting. We found that levels of argin-
ase-1 activity in the serum from ATB patients showed a positive 
linear correlation with the extent of lung inflammatory damage 
as assessed by chest radiographs (Figure 7D). This also coin-
cided with increased relative expression of ARG1 mRNA in CD14+ 
monocytes isolated from peripheral blood of ATB patients when 
compared with LTB patients (Figure 7E). Importantly, we also 
found increased serum arginase-1 activity in ATB patients with 
helminth coinfections when compared with ATB patients without 
helminth coinfections (Figure 7F). These data provide new evi-
dence that, despite the well-known role for arginase-1 in impairing 
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both neutrophils and eosinophils. These data suggest that accu-
mulation of helminth infection–induced arginase-1–expressing 
macrophages in the lungs initiates the formation of inflammatory 
rather than protective granulomas during TB. The fact that S. man-
soni/Mtb–coinfected BMC mice that lack arginase-1–expressing 
macrophages exhibit decreased lung inflammation and increased 
formation of protective B cell follicles provides direct evidence that 
helminth-induced arginase-1 expression in myeloid cells mediates 
disease exacerbation in coinfected hosts. Interestingly, in a dermal 
Mtb-infection model resulting in hypoxic lung granulomas, absence 
of arginase-1 in macrophages resulted in exacerbated inflam-
mation in iNOS-deficient mice (21). It is possible that arginase-1 
expression in macrophages can function to either limit or exacer-
bate inflammation, depending upon the availability or absence of 
iNOS, and this needs to be carefully examined in the future. In the 
context of pulmonary Mtb infection, macrophages were found to 
express either iNOS or ariginase-1, or coexpress both iNOS and 
arginase-1, with the arginase-1–expressing macrophages localized 
to lymphocytic cuffs of granulomas in Mtb-infected macaques 
(31). Accordingly, Mtb infection can induce arginase-1 expression 
in macrophages (18), and high levels of both arginase-1 and iNOS 
activity was detected in Mtb-infected macaque granulomas (31). 
Consistent with these studies, the correlation between increased 
arginase-1 expression and increased inflammation in genetically 
diverse outbred mice and humans with ATB in our study further 
suggests that genetic factors that drive increased arginase-1 pro-
duction may contribute to increased pathology and disease sever-
ity during TB. Importantly, similar to the mouse model of coin-
fection, we detected increased arginase-1 activity in the serum of 
ATB patients coinfected with helminths when compared with ATB 
patients without helminth coinfections. This is consistent with the 
presence of arginase-1–expressing macrophages within granulo-
mas found within lungs of TB patients (31, 32), where arginase-1 is 
expressed both in granuloma-associated macrophages (31, 32) and 
in type II pneumocytes (32). Arginine is a crucial amino acid that 
modulates immune responses to Mtb, as it is a common substrate 
for both iNOS and arginase-1. Loss of arginase-1 in macrophages 
enhances protection against Mtb, possibly due to increased avail-
ability of arginine for iNOS activity (18). Interestingly, Mtb infec-
tion in mice deficient in arginase-1 expression within macrophages 
also exhibits smaller, more lymphocytic granulomas (18), further 
supporting our hypothesis that arginase-1 regulates inflammation 
within TB granulomas. Based on these data, we propose that argi-
nase-1 induced due to helminth coinfections, helminthic products, 
and host genetics mediates the formation of more inflammatory 
TB granulomas. Finally, increased reactivation of Mtb infection 
after SEA treatment suggests that helminth coinfection likely facil-
itates increased TB reactivation rates.
Arginase-1 has been implicated in models of lung injury, where 
increased expression of arginase-1 coincides with collagen depo-
sition and fibrosis in pulmonary diseases such as asthma, cystic 
fibrosis, idiopathic pulmonary fibrosis (IPF), and chronic obstruc-
tive pulmonary disease (COPD) (33). In animal models of silicosis, 
another inflammatory lung disease characterized by fibrosis, argi-
nase activity and arginase-1 expression are enhanced in alveolar 
macrophages (33). In contrast, in S. mansoni–induced Th2-driven 
inflammation, macrophage-specific arginase-1 was demonstrated 
from the infected lung and that in vitro treatment with SEA has 
an inhibitory effect on Th1 immune responses, as well as on cell 
activation pathways. Similarly, the presence of SEA or S. mansoni 
during Mtb infection in vivo results in a significant inhibition of 
IFN-γ production in T cells (Figure 2E). However, we demonstrate 
that these effects on cytokine production by Th1 cells are transient 
and reversible, as evidenced by their comparable ability to pro-
duce IFN-γ following in vitro restimulation. In addition, removal 
of SEA restores IFN-γ production and the ability to activate alve-
olar macrophages to control Mtb infection. The discrepancy 
between our ex vivo flow cytometric analysis using reporter mice 
and our ELISpot results highlights the importance of directly ana-
lyzing immune cell function in the absence of additional restimu-
lation in vitro. The differential assays used in the various studies 
may in part be responsible for the variability in the impairment 
of Mtb-specific Th1 responses observed due to helminth infec-
tions across studies (7, 11, 27, 30). Nonetheless, it is quite surpris-
ing that, despite impairment of Th1 responses by treatment with 
SEA in vitro, removal of SEA in culture conditions can reverse this 
impairment. This is further supported by our data that show that 
treatment of S. mansoni infection with an antihelminthic such as 
praziquantel can reverse the accumulation of arginase-1–express-
ing lung macrophages and decrease disease severity during TB. 
These findings are notable and underscore the potential for the 
broad application of antihelminthics as a cost-effective strategy 
to overcome the effects of helminth-driven arginase-1–mediated 
disease severity during TB and to decrease the risk for TB reacti-
vation in susceptible, coinfected individuals.
Our data demonstrate that, while the effects of Schistosoma 
coinfection on Mtb control are small but significant, its influence 
on Mtb-induced lung inflammation and pathology are dramatic. 
Considering that the Mtb burden was not profoundly different in 
coinfected mice when compared with Mtb-infected mice, the exac-
erbated inflammation observed in coinfected hosts is likely not 
due to differences in the mycobacterial antigenic load. Instead, 
we demonstrate that helminth infection results in induction of 
high arginase-1–expressing macrophages within the lung, which 
are organized as type 2 granulomas and are morphologically and 
functionally different from the type 1 granulomas containing high 
iNOS–expressing macrophages induced in response to Mtb infec-
tion. The induction of high arginase-1–expressing macrophages 
results in increased lung pathology in the S. mansoni/Mtb–coin-
fected hosts, projecting an inflammatory role for arginase-1 in 
Mtb infection. These data are further supported by the increased 
expression of Arg1 mRNA expression in CD11c+ lung cells and 
increased inflammation observed in SEA-treated Mtb-infected 
mice, suggesting that the presence of Schistosoma antigens is suffi-
cient to induce inflammation and lung pathology during Mtb infec-
tion. Our recent studies showed that the presence of B cell follicles 
harboring T cells interacting with macrophages within granulomas 
are associated with Mtb control during TB latency (13), while the 
presence of granulocytes within the tubercle granulomas causes 
increased inflammation and exacerbates disease severity in clini-
cal disease (14). Accordingly, the increased inflammation associ-
ated with Schistosoma coinfection and SEA immunization results 
in reduced formation of protective lymphoid follicles, with the 
concomitant formation of inflammatory granulomas containing 
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tion, traction bronchiectasis, irregular interfaces, and parenchymal 
bands. We developed a quantitative scale for measuring the degree of 
lung damage, according to the profusion of pulmonary abnormalities. 
The pulmonary parenchyma was evaluated in 4 quadrants, with the 
division between the upper and lower lung in both sides being arbi-
trarily set at the carina section. Each quadrant was scored from 0–5, 
where 0 denoted absence of lesions and 5 was the maximum affection. 
The score represented the percentage of lung parenchyma involve-
ment. The maximum score for the 4 lung zones was 20 (14). The 
images were blinded, and the same image was read twice separately 
by an experienced observer (pulmonologist researcher). The reported 
score is the mean of 2 measurements.
Buffy coats from 20 ml of EDTA anticoagulated peripheral blood 
from ATB and LTB patients who signed an informed consent letter were 
obtained at the TB clinic of the INER. Total peripheral blood mononu-
clear cells (PBMCs) were obtained by density gradient centrifugation 
using Lymphoprep (Axis-Shield). CD14+ monocytes were purified using 
magnetic beads (Miltenyi Biotec). Purity of isolated monocytes was 
assessed by flow cytometry using anti-human monoclonal antibodies: 
CD14-FITC and CD3–PE-Cy7 (BioLegend), obtaining >97% purity. 
Total RNA was isolated from monocytes for quantitative PCR (qPCR) 
expression assays using validated TaqMan assays (ThermoFisher).
In samples collected from NIH-NIRT-ICER, we studied a group 
of 44 individuals with active pulmonary TB, 22 of whom were infected 
with the helminth Strongyloides stercoralis. Active pulmonary TB was 
diagnosed microbiologically on the basis of being at least culture pos-
itive for Mtb by solid cultures in Lowenstein Jensen medium; some 
were also sputum smear positive. Strongyloides infection was diag-
nosed by the presence of IgG antibodies to the 31-kDa recombinant 
NIE antigen by the luciferase immunoprecipitation system assay, as 
described previously (34).
Animals. C57BL/6 mice were purchased from Taconic, and IFN-γ–
YFP reporter mice were obtained from Markus Mohrs (Trudeau Insti-
tute, Saranac Lake, New York, USA) (35). ESAT-6 Tg mice, expressing 
the αβ TCR specific for the IAb-presented ESAT-61–20 peptide, were pro-
vided by G. Winslow (Wadsworth Center, Albany, New York, USA) and 
D. Woodland (Trudeau Institute) (36). The ESAT-6 TCR Tg mice were 
maintained on the Rag1–/– background. Yarg, Cd4–/–, C57BL/6.SJL, and 
DO mice were purchased from The Jackson Laboratory. Tie2-Cre Arg1fl/fl, 
Lysm-CreArg1fl/fl BM, and Arg1fl/fl (WT) mice were used as before (18). 
Mice strains were bred and maintained in house either at the University 
of Pittsburgh or Washington University in St. Louis. Experimental mice 
were age- and sex-matched and used between the ages of 6–8 weeks in 
accordance with University of Pittsburgh and Washington University in 
St. Louis Animal Care and Use Committee guidelines.
Mtb aerosol infection, S. mansoni infection, and immunizations. Mtb 
strain H37Rv was cultured in Proskauer Beck medium containing 
0.05% Tween 80 to mid-log phase and was frozen in 1 ml aliquots at 
–80°C. For Mtb infections, animals were aerosol infected with approxi-
mately 100 CFU of bacteria using a Glas-Col airborne infection system. 
At given time points, organs were harvested and homogenized, and 
serial dilutions of tissue homogenates were plated on 7H11 agar plates 
supplemented with oleic albumin dextrose catalase (OADC). Addition-
ally, lung samples were processed for RNA extraction, histology, and 
cytokine determination. For S. mansoni/Mtb coinfections, mice were 
infected by percutaneous exposure to 55 S. mansoni cercariae (Puerto 
Rican/Naval Medical Research Institute strain) 6 weeks prior to Mtb 
to function as a suppressor of fibrosis (19). Our studies demonstrate 
that, in the lungs of mice coinfected with Schistosoma and Mtb, 
increased accumulation of arginase-1–expressing macrophages 
organized as type 2 granulomas results in increased collagen 
expression and increased Mmp13 and Mip1a mRNA expression 
(data not shown), which are molecules implicated in lung fibrosis 
(33). The fact that accumulation of arginase-1–expressing macro-
phages coincides with exacerbated inflammation in a Th1-domi-
nated disease such as TB is unexpected, as other models of acute 
and chronic Th2-mediated lung inflammation showed neither a 
pathogenic nor a protective role for myeloid-expressed arginase-1 
(20). In addition, our data show that praziquantel treatment in coin-
fected mice is able to control S. mansoni infection to fully reverse 
the increased inflammation and higher Mtb bacterial burden seen 
in coinfected mice to levels seen in Mtb-infected mice. This is in 
contrast with the coinfection in BMC mice specifically lacking argi-
nase-1 expression in macrophages, where increased inflammation 
is reversed but increased Mtb burden is unaffected. In our studies, 
we have used the Tie2-Cre Arg1fl/fl mice to delete arginase-1 expres-
sion in all myeloid cells, and the Lysm-Cre Arg1fl/fl mice to delete 
arginase-1 specifically in macrophages and neutrophils. Consistent 
with our data that macrophages are the primary arginase-1–pro-
ducing cells in the coinfected lung, generation of BMC mice using 
BM cells from either Tie2-Cre Arg1fl/fl mice or Lysm-Cre Arg1fl/fl mice 
ablated the accumulation of lung macrophages producing argin-
ase-1 in coinfected mice and reversed lung inflammation. These 
data together suggest that, while the increased inflammation seen 
in coinfected mice is helminth driven and arginase-1 dependent, 
the increase in Mtb burden — although helminth driven — is not 
directly dependent on arginase-1 expression in macrophages. 
Future studies delineating the specific mechanisms by which hel-
minth-induced responses drive the fibrosis and increased inflam-
mation in a Th1 disease such as TB will shed further light on the 
mechanisms of Mtb control, disease, and TB reactivation in hel-
minth/TB–coinfected populations.
In conclusion, our data suggest that, contrary to the well-
known antiinflammatory role for arginase-1 and its inhibitory 
effects on Th1 responses, arginase-1 has a prominent role in 
driving inflammation and mediating lung damage during TB. 
These data provide new insights into the mechanisms by which 
helminth coinfections drive increased susceptibility and disease 
progression in TB. In addition, our data show that the effects of 
helminth products on impairment of Th1 responses are reversible 
and support the use of antihelminthics as a cost-effective strat-
egy to improve M. bovis BCG vaccination, boost efficient immune 
responses against Mtb, and decrease the risk for TB reactivation in 
susceptible, coinfected individuals.
Methods
Human tissue samples and patient diagnosis. Fresh blood samples from 
ATB patients were obtained from patients recruited to the Tubercu-
losis Outpatient Clinic (INER, Mexico City, Mexico, or NIH-NIRT-
ICERT). Serum samples from all patients with ATB were collected 
prior to anti-Mtb treatment and did not present comorbidities such as 
diabetes, HIV, cancer, and COPD. For ATB patients, chest radiographs 
were assessed for the presence, distribution, and extent of pulmonary 
abnormalities, such as airway consolidation and fibrosis, lung distor-
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Flow cytometry. Single cell lung suspensions from lung tissue were 
stained with fluorochrome-labeled antibodies specific for CD3 ( clone 
145-2C11), CD4 (clone RM4-5), CD44 (clone IM7), CD11c (clone 
HL3), CD11b (clone M1/70), MHCII (clone M5/114.15.2), CD49B 
(clone DX5), FcεRI (clone MAR-1), F4/80 (clone BM8), Siglec-F (clone 
E50-2440), CD8a (clone 53-6.7), CD117 (clone 2B8), Gr-1 (clone RB6-
8C5), or isotype control antibodies (BD Biosciences). For intracellular 
cytokine staining, lung cell suspensions were stimulated with 50 ng/
ml PMA (Sigma-Aldrich), 750 ng/ml ionomycin (Sigma-Aldrich), and 
GolgiStop (BD Biosciences) for 5 hours at 37°C. Following Fc block 
incubation (BD Biosciences), surface staining was carried out. Cells 
were then permeabilized with Cytofix-Cytoperm solution (BD Biosci-
ences) and stained with anti–IFN-γ (XMG1.2) or anti–IL-4 (11B11) (BD 
Biosciences). Cells were analyzed using a BD LSR II flow cytometer 
using FACS Diva software (BD Biosciences). Cells were gated based on 
their forward by side scatter characteristics, and the frequency of spe-
cific cell types was calculated using FlowJo. Mean fluorescence inten-
sity was also determined to define expression levels of different mol-
ecules using FlowJo. Lung macrophages and neutrophils were sorted 
from lung single cell suspensions prepared from coinfected mice on 
a FACsJazz (BD Biosciences) instrument using fluorochrome-labeled 
antibodies. Lung macrophages were identified as F4/80+CD11c+ cells, 
while neutrophils were identified as Gr1+/CD11b+ cells, with resulting 
purity of >95% for sorted macrophages and >85% for neutrophils.
Real-time PCR. RNA was extracted using the RNeasy kit (QIAGEN), 
and cDNA was then amplified with FAM-tagged probes and PCR prim-
ers on a Viia7 thermocycler. Specific gene expression was calculated 
relative to Gapdh mRNA expression. Primer and probe sequences tar-
geting specific genes were commercially purchased (ABI Biosystems).
Detection of IFN-γ–producing cells by ELISpot. ESAT-61–20–specific 
IFN-γ–producing CD4+ T cells from infected lungs were quantified 
using peptide-driven ELISpot. Briefly, 96-well ELISpot plates were 
coated with monoclonal anti–mouse IFN-γ (clone R46A2, eBioscience) 
in phosphate-buffered saline and blocked with media supplemented 
with 10% FBS. Cells from lungs were plated at an initial concentration 
of 5 × 105 cells/well, and serial 2-fold dilutions were made. Restimu-
lation was carried out in the presence of 1 × 106 cells/well C57BL/6 
irradiated splenocytes, ESAT-61–20 peptide (10 μg/ml), and mouse rIL-2 
(10 U/ml). After 24 hours, plates were washed and probed with bioti-
nylated anti–mouse IFN-γ (XMG1.2, eBioscience). Spots were enumer-
ated using a CTL-immunospot S5 MicroAnalyzer (Cellular Technology 
Limited). No spots were detected in cultures lacking antigen.
RNA seq. Total RNA was isolated using the RNEasy Mini kit 
(QIAGEN), and RNA integrity was determined with the Agilent 2100 
Bioanalyzer. Briefly, mRNA was purified from 2–5 μg of total RNA 
using Sera-Mag Oligo(dT) Beads, fragmented with magnesium- 
catalyzed hydrolysis, and reverse transcribed into cDNA using ran-
dom primers (Superscript II; Invitrogen). Then, cDNA underwent 
end repair with T4 DNA polymerase and Klenow DNA polymerase, 
followed by the addition of ‘A’ bases to the 3′ end and ligation to adap-
tor oligos. Products from the ligation were run on a 2% agarose gel. 
A gel slice consisting of the 200 bp region (± 25 bp) was excised and 
used as a template for PCR amplification. The final PCR product was 
purified, denatured with 2 N NaOH, and diluted to 10–12 pM prior to 
cluster amplification on a single-read flow cell v4, as outlined in the 
Single-Read Cluster Generation Kit v4 (Illumina). The flow cell was 
sequenced on an Illumina Genome Analyzer II.
aerosol challenge. S. mansoni liver egg burden was determined by over-
night digestion of the liver in 4% KOH at 37°C. Eggs were enumerated 
by microscopic observation of the liver suspensions. SEA was prepared 
as described before (37). For immunizations, 50 μg of SEA, BSA, or 
PPD were s.c. administered to mice as described before (37).
Antihelminthic treatment. S. mansoni treatment was performed by 
oral gavage with 6.25 mg of praziquantel in a volume of 300 μl (38). 
S. mansoni/Mtb–coinfected mice received 3 doses of praziquantel 
24, 72, and 120 hours following Mtb infection. Control mice instead 
received 300 μl of PBS.
Generation of BMC mice. To generate BMC mice, we treated 
C57BL/6.SJL mice with Sulfamethoxazole and Trimethroprim (Hi-Tech 
Pharmacal) in the drinking water for 2 weeks prior to irradiation. Mice 
were sublethally irradiated with 1,000 rad and were reconstituted with 
5 × 106 to 10 × 106 BM cells from either WT control (Arg1fl/fl) or Tie2-Cre 
Arg1fl/fl mice or Lysm-Cre Arg1fl/fl via i.v. injection as before (13). Mice 
were allowed to reconstitute for 6 weeks while continuing to receive 
antibiotic water, after which they were used in experimental proce-
dures. BM reconstitution was verified by flow cytometric analysis of 
peripheral blood cells.
Modified Cornell mouse model of LTB. C57BL/6 mice were aerosol 
infected with approximately 100 CFU of Mtb H37Rv using a Glas-Col 
airborne infection system and rested for 30 days. Mice were subse-
quently treated for 6 weeks with rifampicin (100 mg/l) and isoniazid 
(200 mg/l) in the drinking water (14). After a 2-week period, mice 
received either 2 s.c. immunizations of 50 μg SEA or PBS. Lung and 
spleen bacterial burden was determined 2 weeks after the second 
immunization, as described above.
CD4+ T cell isolation, in vitro T cell differentiation and restimulation. 
Single cell suspensions from DNAse/collagenase-treated lung tissue or 
spleen were prepared as previously described (39). CD4+ T cells from 
secondary lymphoid organs of ESAT-6 TCR Tg mice or from the lungs 
of Mtb-infected mice were isolated using magnetic CD4+ beads (clone 
GK1.5, Miltenyi Biotec), according to the manufacturer’s instructions. 
For SEA treatment, cells were incubated in the presence of irradiated 
splenocytes, 5 μg/ml ESAT-6 peptide, 10 U/ml IL-2 with 50 μg/ml SEA. 
T cells were incubated for 6 days at 37°C and 5% CO2 and supplemented 
with an equivalent volume of media containing IL-2 (10 U/ml) on day 3. 
Control cells were incubated using the same peptide and cytokine con-
centrations in the absence of SEA. After 6 days, T cells were restimu-
lated with irradiated splenocytes and 5 μg/ml ESAT-6 peptide for 48 
hours. Tissue culture supernatants were then harvested and used in 
ELISA, while cell pellets were processed for RNA extraction.
Arginase-1 activity determination. Arginase-1 activity in serum or lung 
homogenates was determined using the QuantiChrom Arginase Assay 
Kit (BioAssay Systems). For serum samples, urea was eliminated by per-
forming 2 washes with PBS through Amicon Ultra 0.5 (10 kDa cutoff, 
Millipore). For lung homogenates, protein concentration was adjusted 
to 100 μg/ml. Sample (40 μl) was incubated at 37°C for 120 minutes in 
the presence or absence of 10 μl of 5× assay reagent. Urea levels were 
subsequently detected and calculated according to the manufacturer’s 
instructions. Arginase-1 activity is expressed as U/l of sample.
Cytokine and chemokine protein determination. Culture superna-
tants or lung homogenates were generated, and cytokine and chemo-
kine concentrations were determined by sandwich ELISA (Mouse 
DuoSet ELISA, R&D Systems) or Luminex (Millipore), according to 
the manufacturer’s instructions.
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the end of the culture period, macrophages were washed twice with 
PBS and lysed by a 5-minute incubation with 0.05% SDS. Following 
SDS neutralization with 10% BSA, intracellular Mtb burden was deter-
mined by plating of serial dilutions on 7H11 plates.
Detection of nitrites by the Griess reaction. Culture supernatants 
were assessed for nitrite production by using the Griess Reagent Sys-
tem Kit (Promega), according to the manufacturer’s instructions.
Statistics. Differences between the means of multiple experimen-
tal groups were analyzed using one-way ANOVA with Tukey’s post-
hoc test. For all other analyses, we used the 2-tailed Student’s t test. 
Correlation between variables was determined by calculating Pear-
son’s coefficient using a 2-tailed analysis. Differences were considered 
significant when P ≤ 0.05. For all figures, data represent mean ± SD. All 
analyses were performed using GraphPad Prism Software.
Study approval. All individuals were examined as part of a clini-
cal research protocol approved by the Institutional Review Board of 
the Tuberculosis Outpatient Clinic, INER, or NIH-NIRT-ICERT, and 
informed written consent was obtained from all participants. All mice 
were used following the NIH guidelines for housing and care of lab-
oratory animals and in accordance with University of Pittsburgh and 
Washington University in St. Louis Institutional Animal Care and Use 
Committee guidelines. All efforts were made to minimize suffering 
and pain, as described in these approved protocols.
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We mapped reads to Mus musculus (mm9) reference transcrip-
tome from GenBank using the Burrows-Wheeler aligner tool. For 
sample-wise data normalization, we applied DESeq using R statistical 
software. To achieve more reliable results, we applied 3 popular meth-
ods for detecting differentially expressed genes (DEGs) using RNAseq 
data: edger, DESeq, and baySeq. We considered genes detected by 
at least 2 methods as DEGs when they had a q-value (FDR) less than 
0.05. Pathway analysis was performed using Ingenuity IPA. P values 
from Fisher’s exact test were adjusted by Benjamini-Hochberg multi-
ple testing correction. All data sets have been deposited in NCBI with 
accession numbers GSE66578 and SRX960261-267.
Morphometric analysis and immunofluorescence. Lungs from 
Mtb-infected mice were inflated with 10% neutral buffered formalin 
and were paraffin embedded. Lung sections were stained with H&E 
stain (Colorado Histo-Prep) and processed for light microscopy. To 
visualize collagen deposition, Gomori’s trichrome staining (Sigma- 
Aldrich) was performed according to the manufacturer’s instructions. 
Mucus was detected by PAS stain. Slides were prepared for immun-
ofluorescent staining by deparaffinization and subsequent rehy-
dration by washes with xylene, alcohol, and PBS. Antigen retrieval 
was performed using a Dako Target Retrieval Solution, followed by 
blocking with 5% (v/v) normal donkey serum and Fc block (5 μg/ml, 
2.4G27). Endogenous biotin was neutralized with avidin, followed by 
biotin (Sigma-Aldrich). Sections were stained with goat anti–mouse 
CD3ε (M-20; Santa Cruz Biotechnology Inc.), rat anti–mouse B220 
(RA3-6B2; BD Biosciences), inducible NO synthase (goat anti-mouse 
[M-19; Santa Cruz Biotechnology Inc.]), F4/80 (MCA497GA, AbD 
Serotec), arginase-1 (rabbit anti–arginase I [H-52; Santa Cruz Bio-
technology Inc.]), and biotin monoclonal mouse anti–mouse Muc5AC 
(45M1; Abcam). Primary antibodies were detected with secondary 
antibodies conjugated to Alexa fluor 568 for iNOS and CD3 (A-11057; 
Invitrogen). Donkey anti-rat Ab conjugated to Alexa Fluor 488 was 
used to visualize B220 (A-21208; Invitrogen), donkey anti-rabbit 
conjugated to FITC was used to visualize arginase-1 (711-095-152; 
Jackson ImmunoResearch Laboratories Inc.). Streptavidin-Alexa 
Fluor 488 was used to visualize Muc5AC (Invitrogen). Slow fade gold 
antifade with DAPI (Invitrogen) was used to counterstain tissues 
and to detect nuclei. Images were obtained with a Zeiss Axioplan 2 
microscope and were recorded with a Zeiss AxioCam digital camera. 
Caudal lobes underwent morphometric analysis in a blinded manner 
using the morphometric tool of Zeiss Axioplan microscope, which 
determines the area defined by the squared pixel value for each gran-
uloma and B cell follicle (13).
In vitro Mtb-killing assay. Bronchoalveolar lavage was performed 
on euthanized naive C57BL/6 mice with sterile PBS containing 0.2 
mM EDTA. Following centrifugation, cells were incubated for 1 hour 
at 37°C, after which adherent cells were used for subsequent stud-
ies. CD4+ T cells from Mtb-infected mice were sorted as previously 
described and treated in the presence or absence of SEA for 6 days. 
Following restimulation, T cells were washed extensively and then lay-
ered over Mtb-infected alveolar macrophages (MOI 1:1) for 6 days. At 
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